• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,520.30 26.76
( 0.03%)
Global Indices
Nasdaq
49,464.98 -3.46
(-0.01%)
Dow Jones
7,130.75 -16.31
(-0.23%)
Hang Seng
58,818.22 342.32
(0.59%)
Nikkei 225
10,604.22 -63.41
(-0.59%)
Forex
USD-INR
93.19 -0.12
(-0.13%)
EUR-INR
109.85 -0.18
(-0.16%)
GBP-INR
126.25 -0.31
(-0.25%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Aristo Bio-Tech & Lifescience Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
76744
INE082101010
54.8360704
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ARISTO
16.03
64.27
EPS(TTM)
Face Value()
Div & Yield %
5.89
10
0.53
 

emerald finance ltd
Gujarat Ambuja Exports commences commercial production of Sodium Gluconate at Hubli plant
Dec 19,2025
Gujarat Ambuja Exports has successfully commenced commercial production at India's first maize starch–based fermentation plant for the manufacturing of Sodium Gluconate, with an installed capacity of 30,000 TPA. The said facility is located at Hubli, Karnataka, and commercial production commenced with effect from 19 December 2025, at approximately 9:45 a.m.

The commencement of commercial operations at this facility represents a significant milestone in the Company's strategic expansion into maize fermentation–based products. The Company plans to further scale up capacity in this maize fermentation–based products by introducing additional products and aims to achieve an aggregate installed capacity of 1,20,000 TPA by the year 2028.